HR 6505 · 115th Congress 2017–2019, ended

Medicare Negotiation and Competitive Licensing Act of 2018

Latest action · Aug 3, 2018 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedJul 25, 2018
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Medicare Negotiation and Competitive Licensing Act of 2018

This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. (Current law prohibits the CMS from doing so.)

The CMS must take certain factors into account during negotiations, including the clinical- and cost-effectiveness of the drug, the financial burden on patients, and unmet patient needs. If the CMS is unable to negotiate the price of a drug, such drug is subject to competitive licensing in order to further its sale under Medicare, notwithstanding existing government-granted exclusivities.

Additionally, for one year after a drug is provided under a competitive license, such drug is also subject to specified price limitations; if the drug is not offered at such prices, the drug is subject to additional licensing that furthers its sale under any federal program (e.g., Medicaid).

Cosponsors 104

Members who signed on, in the order they did. Signatures ran from Jul 25, 2018 to Dec 20, 2018; 79 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-NYAdriano EspaillatOriginalJul 25, 2018
D-TXAl GreenOriginalJul 25, 2018
D-FLAl Lawson, Jr.OriginalJul 25, 2018
D-CAAlan S. LowenthalOriginalJul 25, 2018
D-FLAlcee L. HastingsOriginalJul 25, 2018
D-NCAlma S. AdamsOriginalJul 25, 2018
D-CABarbara LeeOriginalJul 25, 2018
D-MSBennie G. ThompsonOriginalJul 25, 2018
D-MNBetty McCollumOriginalJul 25, 2018
D-CABrad ShermanOriginalJul 25, 2018
D-NYBrian HigginsOriginalJul 25, 2018
D-MDC. A. Dutch RuppersbergerOriginalJul 25, 2018
D-NHCarol Shea-PorterOriginalJul 25, 2018
D-NYCarolyn B. MaloneyOriginalJul 25, 2018
D-FLCharlie CristOriginalJul 25, 2018

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Jul 25, 2018
Health Subcommittee
Referred Jul 27, 2018
HouseWays and Means Committee
Referred Jul 25, 2018
Health Subcommittee
Referred Aug 3, 2018

Actions 4

Everything that happened, newest first.

  1. Aug 3, 2018Referred to the Subcommittee on Health.
  2. Jul 27, 2018Referred to the Subcommittee on Health.
  3. Jul 25, 2018Introduced in House
  4. Jul 25, 2018Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Clause 1 of Section 8 of Article I of the United States Constitution.

The sponsor’s statement, as printed in the Congressional Record, vol. 164, no. 125, July 25, 2018, page H7687.

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate prices of prescription drugs furnished under part D of the Medicare program.
Short Titles as Introduced
Medicare Negotiation and Competitive Licensing Act of 2018

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Jul 25, 2018Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.